Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Abstract Full Text (PDF, 346K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Borkowski, T. A. Articles by Udey, M. C. Search for Related Content PubMed PubMed Citation Articles by Borkowski, T. A. Articles by Udey, M. C. Social Bookmarking                            What's this?

Brief Definitive Reports

Teresa A. Borkowski^*, John J. Letterio, Andrew G. Farr, and Mark C. Udey^*

From the ^* Dermatology Branch and the Laboratory of Chemoprevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1908; and the Department of Biological Structure, University of Washington, Seattle, Washington 98195

	Abstract

Top Abstract Materials and Methods Results Discussion References

 
Transforming growth factor β1 (TGF-β1) regulates leukocytes and epithelial cells. To determine whether the pleiotropic effects of TGF-β1, a cytokine that is produced by both keratinocytes and Langerhans cells (LC), extend to epidermal leukocytes, we characterized LC (the epidermal contingent of the dendritic cell [DC] lineage) and dendritic epidermal T cells (DETC) in TGF-β1 null (TGF-β1 –/–) mice. I-A⁺ LC were not detected in epidermal cell suspensions or epidermal sheets prepared from TGF-β1 –/– mice, and epidermal cell suspensions were devoid of allostimulatory activity. In contrast, TCR-⁺ DETC were normal in number and appearance in TGF-β1 –/– mice and, importantly, DETC represented the only leukocytes in the epidermis. Immunolocalization studies revealed CD11c⁺ DC in lymph nodes from TGF-β1 –/– mice, although gp40⁺ DC were absent. Treatment of TGF-β1 –/– mice with rapamycin abrogated the characteristic inflammatory wasting syndrome and prolonged survival indefinitely, but did not result in population of the epidermis with LC. Thus, the LC abnormality in TGF-β1 –/– mice is not a consequence of inflammation in skin or other organs, and LC development is not simply delayed in these animals. We conclude that endogenous TGF-β1 is essential for normal murine LC development or epidermal localization.

Transforming growth factor-β (TGF-β) is comprised of three isoforms (β1, β2, and β3) that are frequently coexpressed, that bind to the same receptor complex, and that initiate similar biochemical changes in target cells in vitro (1, 2). Thus, it is surprising that the phenotype of the homozygous null mutant of the murine gene encoding one of these proteins, TGF-β1, is catastrophic. Although 50% of TGF-β1 –/– and 25% of TGF-β1+/– embryos experience prenatal demise, at birth TGF-β1 –/– mice are normally formed and indistinguishable from +/+ and +/– littermates until postnatal d 10 (3–5). Thereafter, TGF-β1 –/– mice exhibit a progressive wasting syndrome that results from inflammation involving several organs that invariably eventuates in death by postnatal d 30 (4, 5). The inflammation in TGF-β1 –/– mice is lymphocyte and macrophage predominant, involves lungs, heart, liver, and other organs (4, 5), and is associated with production of various autoantibodies (6, 7). Abnormalities in cytokine production (3), MHC antigen expression (8), and nitric oxide metabolism (9) have also been identified in TGF-β1 –/– mice, but the relationship of these findings to the genesis of the phenotype is uncertain.

The epidermal microenvironment is TGF-β1 rich; Langerhans cells (LC) as well as keratinocytes produce this pleiotropic cytokine (10–12). Previous studies of TGF-β1 –/– mice demonstrated that TGF-β1 plays an important role in epidermal homeostasis. Keratinocytes of TGFβ1 –/– mice are hyperproliferative in vivo as well as in vitro, and are predisposed to undergo malignant transformation (10, 13). To determine whether abnormalities in epidermal homeostasis extend to resident leukocytes in skin, we characterized epidermal LC and dendritic epidermal T cells (DETC) in TGF-β1 –/– mice. Our results implicate TGF-β1 as a critical endogenous regulator of murine epidermal LC.

	Materials and Methods

Top Abstract Materials and Methods Results Discussion References

 
Mice.
TGF-β1 –/– and littermate control (+/+) mice were derived from matings of mice that were heterozygous for a null mutation of the TGF-β1 gene (generated [4] and supplied by A. Kulkarni and S. Karlsson [National Institute of Neurological Disorders and Stroke, Bethesda, MD]). Since their derivation, heterozygous males have been backcrossed to C57BL/6 females four times and the colony has been maintained by interbreeding. Thus, although mice in this colony express only H-2^b MHC antigens, each animal has a mixture of 129Sv and C57BL/6 background genes and is unique. TGF-β1 –/– and littermate control mice used in these studies were reared in a pathogen-free facility and were used at 8–20 d of age. All animals were housed and used in experiments in accordance with institutional guidelines.

Preparation of Epidermal Cell Suspensions and Epidermal Sheets.
Epidermal cell suspensions were prepared from trunk skin by limited trypsinization (0.25% trypsin [USB, Cleveland, OH] in HBSS without calcium or magnesium at 4°C for 18 h) and trituration in HBSS, 0.05% DNase, 30% FCS. Epidermal sheets were prepared from ear skin by incubation in 0.5 M ammonium thiocyanate (37°C for 20 min), fixed in acetone (–20°C for 30 min), and rehydrated in PBS (14).

Flow Cytometry and Immunofluorescence Microscopy.
Hybridomas secreting mAb Y3-P (anti-I-A^b), MK-D6 (anti-I-A^d), and N418 (anti-CD11c) were obtained from American Type Culture Collection (Rockville, MD). G8.8 (anti-gp40) was produced and characterized as described (15). mAbs Y3-P, MK-D6, and N418 were purified from hybridoma supernatants by protein A affinity chromatography (Pierce Chemical Co., Rockford, IL); G8.8 was purified using protein G (Pierce Chemical). These mAb were modified with FITC (Sigma) or NHS–LC–biotin (Bio; Pierce Chemical) as described (16). The following mAbs were purchased from PharMingen (San Diego, CA): FITC–anti-TCR-β (H57-597), FITC–anti-TCR- (GL3), FITC–Thy-1.2 (30-H12), Bio–anti-CD45 (30F11.1), and relevant isotype controls. Phycoerythrin– streptavidin (PE–SA) was purchased from TAGO, Inc. (Burlingame, CA).

For flow cytometry, cells were suspended in cold PBS containing 5% FCS and 0.01% NaN₃ and preincubated with saturating concentrations of 2.4G2 (anti-FcRII [17]) followed by FITC–mAb, Bio–mAb, and PE–SA. Surface antigen expression was analyzed using a FACScan^® flow cytometer equipped with Research Software (Becton Dickinson, Mountain View, CA). Propidium iodide permeable cells were excluded by live gating. Epidermal sheets were stained for LC and DETC with FITC–anti-I-A or FITC–anti-TCR mAb diluted in PBS/FCS/NaN₃, washed, and analyzed by epifluorescence microscopy.

Primary Allogeneic Reactions.
Epidermal cells derived from trunk skin of TGF-β1 –/– and control mice were cocultured in flatbottomed 96-well plates with 2 x 10⁵ accessory cell–depleted T cells prepared from the skin-associated lymph nodes of female BALB/c mice (18) for 120 h at 37°C. [³H]TdR (1 µCi/well) was added for the final 12 h of the culture period. Cell-associated radioactivity was determined by direct β counting.

Immunohistochemistry.
Cells reactive with various lineageselective mAbs were localized in lymph nodes using a three-step immunohistochemical procedure (19). In brief, acetone-fixed frozen sections of tissues were washed with PBS and incubated with hybridoma supernatants. After washing, mAbs were detected using digoxigenin-modified anti-rat (or anti-hamster) IgG Ab (Pierce Chemical), peroxidase-conjugated sheep anti-digoxigenin Fab, and 3,3'-diaminobenzidine. Digoxigenin-3-O-methylcarbonyl--aminocaproic acid, N-hydroxy-succinimidyl ester, and anti-digoxigenin Ab were purchased from Boehringer Mannheim (Indianapolis, IN) and used as suggested by the manufacturer.

Rapamycin Treatment.
Rapamycin (Wyeth-Ayerst; Princeton, NJ) was dissolved in 0.2% high viscosity carboxymethyl cellulose (Sigma)/0.25% polysorbate 80 in dH₂0 and administered to all progeny resulting from the mating of several breeding pairs of TGF-β1+/– mice by i.p. injection (4 mg/kg) on postnatal day 10 and 3x/wk thereafter.

	Results

Top Abstract Materials and Methods Results Discussion References

 
Epidermal Leukocytes in TGF-β1 –/– Mice.
To begin to characterize epidermal leukocytes in TGF-β1 –/– mice, cells were prepared from the trunk skin of –/– and +/+ littermates and examined for the simultaneous expression of CD45 and I-A antigens, and CD45 and TCR- (or Thy1.2) via multicolor flow cytometry. Although TGF-β1 +/+ mice contained a normal contingent of LC (CD45⁺ I-A^b+ cells), LC could not be identified in TGF-β1 –/– epidermis (see Fig. 1 for results with 17-d-old mice). However, the frequency of DETC (CD45⁺ TCR-⁺ cells) among TGF-β1 –/– epidermal cells was normal. In addition, essentially all of the leukocytes (CD45⁺ cells) present in TGF-β1 –/– epidermis were DETC. This latter result excludes the existence of a significant population of immature LC (CD45⁺ I-A^b– TCR-^– cells) in TGF-β1 –/– epidermis. The CD45^– I-A⁺ cells detected in TGF-β1 –/– epidermis (see Fig. 1 a) represent keratinocytes that inappropriately express class II MHC antigens; this finding is consistent with the previous report of disordered MHC Ag expression in TGF-β1 –/– mice (8). The LC deficiency in TGF-β1 –/– mice was confirmed in six additional experiments with mice ranging in age from 7–18 d (Table 1). Younger animals were not studied because normal numbers of epidermal LC would not be expected before postnatal day 7. Older animals were not studied because the health status of TGF-β1 –/– mice deteriorates rapidly after 18 d.

View larger version (67K): [in this window] [in a new window] [Download PPT slide]   Figure 1 TGF-β1 –/– mice lack epidermal LC. Epidermal cell suspensions were prepared from the trunk skin of 17-d TGF-β1 –/– and littermate control mice, stained for CD45 and I-A antigens (or CD45 and TCR-), and analyzed using multicolor flow cytometry. Nonviable cells were excluded during data acquisition. Markers were adjusted such that cells stained with isotype control reagents were contained within the left lower quadrant of each panel.

 

View this table: [in this window] [in a new window]   Table 1 Leukocytes in Epidermal Cell Suspensions from TGF-β1 Null and Control Mice

 
LC were also quantitated in TGF-β1 –/– and wildtype epidermis in situ. Immunofluorescence microscopy of epidermal sheets prepared from the ear skin of TGF-β1 –/– mice confirmed that LC were absent; DETC were normal in number and morphology (data not shown). In addition, epidermal cell suspensions from TGF-β1 –/– mice failed to initiate a proliferative response in naive BALB/c T cells (Fig. 2). Thus, LC (or LC precursors) could not be detected in the epidermis of TGF-β1 –/– mice, or in epidermal cell suspensions prepared from these animals, using assays of LC surface phenotype or function.

View larger version (19K): [in this window] [in a new window] [Download PPT slide]   Figure 2 TGF-β1 –/– epidermis is deficient in allostimulatory activity. Epidermal cells from the trunk skin of TGF-β1 –/– and +/+ mice were incubated with BALB/c lymph node T cells (2 x 105/well) in flatbottomed microtiter plates for 120 h. [3H]TdR was added (1 µCi/well) for the last 12 h of the incubation. Cell-associated radioactivity was measured by direct β counting. Closed circles, epidermal cells from TGF-β1 –/– mice; closed squares, epidermal cells from +/+ controls.

 
Lymphoid Dendritic Cells in TGF-β1 –/– Mice.
LC represent the epidermal contingent of the dendritic cell (DC) lineage (20). To determine whether lymphoid DC were present in TGF-β1 –/– mice, we examined skin-draining lymph nodes for several leukocyte subpopulations. Axillary lymph nodes were sectioned and stained with several lineage-selective mAbs (see Fig. 3). CD11c⁺ (N418-reactive) DC were readily identified in T cell–dependent regions of lymph nodes from TGF-β1 –/– as well as control mice. In contrast, cells reactive with anti-gp40 (G8.8), another DC-selective mAb (21), were absent from TGF-β1-deficient lymph nodes. F4/80⁺ macrophages were similarly represented and distributed in both TGF-β1 –/– and TGF-β1 +/+ tissue. These results suggest that although lymphoid DC are present in TGF-β1 null mice, all subpopulations may not be normally represented. Alternatively, TGF-β1 may be required for expression of certain lymphoid DC differentiation antigens.

View larger version (131K): [in this window] [in a new window] [Download PPT slide]   Figure 3 Lymphoid dendritic cells are present in TGF-β1 –/– mice. Frozen sections of axillary lymph nodes from a 14-d TGF-β1 –/– mouse and a +/+ littermate control were stained with several lineage-selective markers using a three-step immunohistochemical technique. (a–d) sections from littermate control. (e–h) sections from TGF-β1 –/– mouse. (a and e) anti-gp40 (G8.8). (b and f ) anti-CD11c (N418). (c and g) anti-CD3 (145-2C11). (d and h) anti-macrophage (F4/80).

 
Dissociation of the Langerhans Cell Deficiency from Other Aspects of the TGF-β1 –/– Phenotype.
The TGF-β1 –/– phenotype is characterized by marked inflammation of several major organs, wasting, and death at an early age (3, 4). The skin is not prominently involved in this inflammatory syndrome. Histopathologic examination of 17 d TGF-β1 –/– skin revealed only a sparse interstitial inflammatory infiltrate that was difficult to distinguish from the minimal infiltrate present in controls (data not shown). Nonetheless, to exclude the possibility that aberrant cytokine secretion associated with inflammation (in skin or elsewhere) influenced the ability of LC (or LC precursors) to develop or localize in TGF-β1 –/– epidermis, we assessed the LC content of the skin of TGF-β1 –/– mice that were treated with the immunosuppressive rapamycin (22). Rapamycin (4 mg/kg) was administered i.p. to littermates born to TGF-β1 heterozygotes beginning at 10 d of age and 3x/wk thereafter. This regimen obviated the wasting that is invariably present in untreated TGF-β1 –/– mice older than 14 d (Fig. 4), and almost completely inhibited the inflammation in lungs, heart, and liver that is characteristic of TGF-β1 –/– mice (data not shown).

View larger version (25K): [in this window] [in a new window] [Download PPT slide]   Figure 4 Rapamycin abrogates the fatal wasting syndrome that results from TGF-β1 deficiency. Progeny of TGF-β1 +/– x +/– matings were treated with rapamycin (4 mg/kg i.p.) on postnatal day 10 and 3x/ wk thereafter. Serial weights were determined before each treatment and representative data are depicted.

 
Rapamycin-treated TGF-β1 –/– mice not only survived indefinitely, but gained weight for the duration of the experiments (39 and 42 d). Although the most dramatic components of the TGF-β1 –/– phenotype were eliminated by rapamycin treatment, epidermal sheets from ears of rapamycin-treated TGF-β1 –/– mice were devoid of LC (data not shown), as were epidermal cell suspensions prepared from trunk skin of these mice (Table 2). Rapamycin treatment had no effect on LC in TGF-β1 +/+ or +/– mice and, as in the case of untreated mice, DETC were the only leukocytes present in appreciable numbers in TGF-β1 –/– epidermis. Thus, the LC deficiency in TGF-β1 –/– mice does not result from the inflammatory syndrome that causes the demise of these animals, and cannot be attributed simply to delayed development.

View this table: [in this window] [in a new window]   Table 2 Epidermal Leukocytes in Rapamycin-treated TGF-β1 Null and Control Mice

 

	Discussion

Top Abstract Materials and Methods Results Discussion References

 
TGF-β1 –/– mice represent the first animal model in which an absolute deficiency of LC (or other nonlymphoid DC) has been identified. Decreased numbers of LC were previously documented in the op/op mouse (23), a null mutant of the M-CSF (CSF-1) gene, but the LC deficiency in the TGF-β1 –/– mouse is much more profound. Although the LC deficiency is the most obvious alteration in the DC lineage in TGF-β1 –/– mice, lymphoid DC may also be abnormal. DC expressing gp40 (15, 21) were absent from skin-draining lymph nodes of TGF-β1 –/– mice, whereas CD11c⁺ DC were readily detected. Perhaps gp40-bearing DC in lymph nodes represent a distinct subpopulation of DC that in this site are derived exclusively from epidermal LC. Alternatively, TGF-β1 may modulate cell surface expression of certain DC antigens. The deficiency of epidermal LC in TGF-β1 –/– mice reported here also constitutes one of the most striking abnormalities in hematopoetic cells that has been documented in these animals. Previous studies focused primarily on abnormalities in the representation of mononuclear cell subpopulations in lymphoid tissues, and the immune dysregulation that underlies the inflammatory wasting syndrome that is associated with this genotype (6, 7, 24). The relationship of the LC/DC abnormalities in TGF-β1 –/– mice to other features of the phenotype is unknown, although abnormalities in DC may contribute to the decreased T cell mitogenic responses that are seen in TGF-β1 –/– mononuclear cells (24).

The nature of the requirement for TGF-β1 as a regulator of LC has not been determined. TGF-β1 may be required for proliferation or differentiation of LC precursors. This suggestion is compatible with the recent report that TGF-β1 promotes the in vitro expansion of DC in serumfree cultures of human CD34⁺ hematopoetic progenitors (25). Alternatively, TGF-β1 may influence the ability of LC precursors (or LC) to localize in epidermis or facilitate LC survival. Candidate mechanisms for TGF-β1 action include modulation of cytokine production (3), induction of growth factors or growth factor receptors (26), and regulation of adhesion molecule expression or function (27). Regulation could occur at transcriptional or posttranscriptional levels. Interestingly, there are a number of similarities between TGF-β1 null mice and mice that are deficient in the transcription factor relB (28, 29). Inflammatory syndromes and DC abnormalites are present in both models. RelB –/– mice have LC, but lack lymphoid DC. In contrast, TGF-β1 –/– mice have lymphoid DC, but lack LC. These results, in light of the recent determination that TGF-β1 influences the activity of NF-B/Rel proteins in murine B cells by regulating levels of the inhibitor IB (30), suggest that TGF-β1 may regulate DC via a similar pathway. Resolution of these questions should result in elucidation of mechanisms by which murine LC/DC are regulated in vivo.

	Acknowledgments

This work was supported in part by grants from the National Institutes of Health (AI 24137 and AG 04350 to A.G. Farr).

Submitted: 28 August 1996
Revised: 7 October 1996

	References

Top Abstract Materials and Methods Results Discussion References

 

1 Sporn MB & Roberts AB. Transforming growth factor-β: recent progress and new challenges, J Cell Biol, 1992, 119, 1017–1021.[Free Full Text]

2 Kingsley DM. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms, Genes & Dev, 1994, 8, 133–146.[Free Full Text]

3 Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N & Doetschman T. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease, Nature (Lond), 1992, 359, 693–699.[Medline]

4 Kulkarni AB, Huh C-G, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM & Karlsson S. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death, Proc Natl Acad Sci USA, 1993, 90, 770–774.[Abstract/Free Full Text]

5 Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S & Akhurst RJ. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice, Development, 1995, 121, 1845–1854.[Abstract]

6 Dang H, Geiser AG, Letterio JJ, Nakabayshi T, Kong L, Fernandes G & Talal N. SLE-like autoantibodies and Sjogrens syndrome–like lymphoproliferation in TGFβ knockout mice, J Immunol, 1995, 155, 3205–3212.[Abstract]

7 Yaswen L, Kulkarni AB, Fredrickson T, Mittleman B, Schiffmann R, Payne S, Longnecker G, Moses E & Karlsson S. Autoimmune manifestations in the transforming growth factor-β1 knockout mouse, Blood, 1996, 87, 1439–1445.[Abstract/Free Full Text]

8 Geiser AG, Letterio JJ, Kulkarni AB, Karlsson S, Roberts AB & Sporn MB. Transforming growth factor β1 (TGF-β1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-β1 null mouse, Proc Natl Acad Sci USA, 1993, 90, 9944–9948.[Abstract/Free Full Text]

9 Vodovotz Y, Geiser AG, Chesler L, Letterio JJ, Campbell A, Lucia MS, Sporn MB & Roberts AB. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor β1 null mouse, J Exp Med, 1996, 183, 2337–2342.[Abstract/Free Full Text]

10 Glick AB, Kulkarni AB, Tennebaum T, Hennings H, Flanders KC, O'Reilly M, Sporn MB, Karlsson S & Yuspa SH. Loss of expression of transforming growth factor β in skin and skin tumors is associted with hyperproliferation and a high risk for malignant conversion, Proc Natl Acad Sci USA, 1993, 90, 6076–6080.[Abstract/Free Full Text]

11 Gruschwitz MS & Hornstein OP. Expression of transforming growth factor type beta on human epidermal dendritic cells, J Invest Dermatol, 1992, 99, 114–116.[Medline]

12 Granucci F, Girolomoni G, Lutz MB, Foti M, Marconi G, Gnocchi P, Nolli L & Ricciardi-Castagnoli P. Modulation of cytokine expression in mouse dendritic cell clones, Eur J Immunol, 1994, 24, 2522–2526.[Medline]

13 Glick AB, Lee MM, Darwiche N, Kulkarni AB, Karlsson S & Yuspa SH. Targeted deletion of the TGF-β1 gene causes rapid progression to squamous cell carcinoma, Genes & Dev, 1994, 8, 2429–2440.[Abstract/Free Full Text]

14 Caughman SW, Sharrow SO, Shimada S, Stephany D, Mizouchi T, Rosenberg A, Katz SI & Singer A. Ia+ murine epidermal Langerhans cells are deficient in surface expression of the class I major histocompatibility complex, Proc Natl Acad Sci USA, 1986, 83, 7438–7442.[Abstract/Free Full Text]

15 Farr A, Nelson A, Truex J & Hosier S. Epithelial heterogeneity in the murine thymus: A cell surface glycoprotein expressed by subcapsular and medullary epithelium, J Histochem Cytochem, 1991, 39, 645–653.[Abstract]

16 Holmes K & Fowlkes BJ. Preparation of cells and reagents for flow cytometry, Curr Prot Immunol, 1991, 1, 5.3.2–5.3.4.

17 Unkeless J. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors, J Exp Med, 1979, 150, 580–596.[Abstract/Free Full Text]

18 Tang A & Udey MC. Inhibition of epidermal Langerhans cell function by low dose ultraviolet B radiation: ultraviolet B radiation selectively modulates ICAM-1 (CD54) expression by murine Langerhans cells, J Immunol, 1991, 146, 3347–3355.[Abstract]

19 Lee M-G, Sharrow SO, Farr AG, Singer A & Udey MC. Expression of the homophilic adhesion molecule E-cadherin by immature thymocytes and thymic epithelial cells, J Immunol, 1994, 152, 5653–5659.[Abstract]

20 Steinman RM. The dendritic cell system and its role in immunogenicity, Annu Rev Immunol, 1991, 9, 271–296.[Medline]

21 Borkowski TA, Nelson AJ, Farr AG & Udey MC. Expression of gp40, the murine homolog of human epithelial adhesion molecule (Ep-CAM), by murine dendritic cells, Eur J Immunol, 1996, 26, 110–114.[Medline]

22 Kunz J & Hall MN. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression, Trends Biochem Sci, 1993, 18, 334–338.[Medline]

23 Witmer-Pack MD, Hughes DA, Schuler G, Lawson L, McWilliam A, Inaba K, Steinman RM & Gordon S. Identification of macrophages and dendritic cells in the osteopetrotic (op/op) mouse, J Cell Sci, 1993, 104, 1021–1029.[Abstract]

24 Christ M, McCartney-Francis NL, Kulkarni AB, Ward JM, Mizel DE, Mackall CL, Gress RE, Hines KL, Tian H, Karlsson S & Wahl SM. Immune dysregulation in TGF-β1-deficient mice, J Immunol, 1994, 153, 1936–1946.[Abstract]

25 Strobl H, Riedl E, Schneinecker C, Bello-Fernandez C, Pickl WF, Rappersberger K, Majdic O & Knapp W. TGFβ1 promotes the development of dendritic cells from CD34⁺progenitors, J Immunol, 1996, 157, 1499–1507.[Abstract]

26 Keller JR, Jacobsen SEW, Sill KT, Ellingsworth LR & Ruscetti FW. Stimulation of granulopoiesis by transforming growth factor β: synergy with granulocyte/ macrophage–colony-stimulating factor, Proc Natl Acad Sci USA, 1991, 88, 7190–7194.[Abstract/Free Full Text]

27 Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Bergstresser PR & Terstappen LWMM. Control of lymphocyte recirculation in man II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissueselective homing receptor for skin-homing T cells, J Immunol, 1993, 150, 1122–1136.[Abstract]

28 Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck R-P, Lira S A & Bravo R. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-B/ Rel family, Cell, 1995, 80, 331–340.[Medline]

29 Burkly L, Hession C, Ogata L, Relly C, Marconl LA, Olson D, Tizard R, Cate R & Lo D. Expression of relB is required for the development of thymic medulla and dendritic cells, Nature (Lond), 1995, 373, 531–536.[Medline]

30 Arsura M, Wu M & Sonenshein GE. TGF-β1 inhibits NF-B/Rel activity inducing apoptosis of B cell: transcriptional activation of IB, Immunity, 1996, 5, 31–40.[Medline]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

This article has been cited by other articles:

• Gobel, F., Taschner, S., Jurkin, J., Konradi, S., Vaculik, C., Richter, S., Kneidinger, D., Muhlbacher, C., Bieglmayer, C., Elbe-Burger, A., Strobl, H. (2009). Reciprocal role of GATA-1 and vitamin D receptor in human myeloid dendritic cell differentiation. Blood 114: 3813-3821 [Abstract] [Full Text]  
• Platzer, B., Richter, S., Kneidinger, D., Waltenberger, D., Woisetschlager, M., Strobl, H. (2009). Aryl Hydrocarbon Receptor Activation Inhibits In Vitro Differentiation of Human Monocytes and Langerhans Dendritic Cells. J. Immunol. 183: 66-74 [Abstract] [Full Text]  
• Vitsky, A., Waire, J., Pawliuk, R., Bond, A., Matthews, D., LaCasse, E., Hawes, M. L., Nelson, C., Richards, S., Piepenhagen, P. A., Garman, R. D., Andrews, L., Thurberg, B. L., Lonning, S., Ledbetter, S., Ruzek, M. C. (2009). Homeostatic Role of Transforming Growth Factor-{beta} in the Oral Cavity and Esophagus of Mice and Its Expression by Mast Cells in These Tissues. Am. J. Pathol. 174: 2137-2149 [Abstract] [Full Text]  
• Ogawa, Y., Kawamura, T., Kimura, T., Ito, M., Blauvelt, A., Shimada, S. (2009). Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood 113: 5157-5166 [Abstract] [Full Text]  
• Merad, M., Manz, M. G. (2009). Dendritic cell homeostasis. Blood 113: 3418-3427 [Abstract] [Full Text]  
• Nagao, K., Ginhoux, F., Leitner, W. W., Motegi, S.-I., Bennett, C. L., Clausen, B. E., Merad, M., Udey, M. C. (2009). Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc. Natl. Acad. Sci. USA 106: 3312-3317 [Abstract] [Full Text]  
• Schuster, C., Vaculik, C., Fiala, C., Meindl, S., Brandt, O., Imhof, M., Stingl, G., Eppel, W., Elbe-Burger, A. (2009). HLA-DR+ leukocytes acquire CD1 antigens in embryonic and fetal human skin and contain functional antigen-presenting cells. JEM 206: 169-181 [Abstract] [Full Text]  
• Aluwihare, P., Mu, Z., Zhao, Z., Yu, D., Weinreb, P. H., Horan, G. S., Violette, S. M., Munger, J. S. (2009). Mice that lack activity of {alpha}v{beta}6- and {alpha}v{beta}8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice. J. Cell Sci. 122: 227-232 [Abstract] [Full Text]  
• Yoshinaga, K., Obata, H., Jurukovski, V., Mazzieri, R., Chen, Y., Zilberberg, L., Huso, D., Melamed, J., Prijatelj, P., Todorovic, V., Dabovic, B., Rifkin, D. B. (2008). Perturbation of transforming growth factor (TGF)-ss1 association with latent TGF-{beta} binding protein yields inflammation and tumors. Proc. Natl. Acad. Sci. USA 105: 18758-18763 [Abstract] [Full Text]  
• Shklovskaya, E., Roediger, B., Fazekas de St. Groth, B. (2008). Epidermal and Dermal Dendritic Cells Display Differential Activation and Migratory Behavior While Sharing the Ability to Stimulate CD4+ T Cell Proliferation In Vivo. J. Immunol. 181: 418-430 [Abstract] [Full Text]  
• Glick, A. B., Perez-Lorenzo, R., Mohammed, J. (2008). Context-dependent regulation of cutaneous immunological responses by TGF{beta}1 and its role in skin carcinogenesis. Carcinogenesis 29: 9-14 [Abstract] [Full Text]  
• Kaplan, D. H., Li, M. O., Jenison, M. C., Shlomchik, W. D., Flavell, R. A., Shlomchik, M. J. (2007). Autocrine/paracrine TGF{beta}1 is required for the development of epidermal Langerhans cells. JEM 204: 2545-2552 [Abstract] [Full Text]  
• Li, G., Abediankenari, S., Kim, Y.-J., Campbell, T. B., Ito, S., Graham-Evans, B., Cooper, S., Broxmeyer, H. E. (2007). TGF-{beta} combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors. Blood 110: 2872-2879 [Abstract] [Full Text]  
• van der Aar, A. M.G., Sylva-Steenland, R. M. R., Bos, J. D., Kapsenberg, M. L., de Jong, E. C., Teunissen, M. B. M. (2007). Cutting Edge: Loss of TLR2, TLR4, and TLR5 on Langerhans Cells Abolishes Bacterial Recognition. J. Immunol. 178: 1986-1990 [Abstract] [Full Text]  
• Jorgl, A., Platzer, B., Taschner, S., Heinz, L. X., Hocher, B., Reisner, P. M., Gobel, F., Strobl, H. (2007). Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB. Blood 109: 185-193 [Abstract] [Full Text]  
• Macia, L., Delacre, M., Abboud, G., Ouk, T.-S., Delanoye, A., Verwaerde, C., Saule, P., Wolowczuk, I. (2006). Impairment of Dendritic Cell Functionality and Steady-State Number in Obese Mice. J. Immunol. 177: 5997-6006 [Abstract] [Full Text]  
• Yoshino, M., Yamazaki, H., Shultz, L. D., Hayashi, S.-I. (2006). Constant rate of steady-state self-antigen trafficking from skin to regional lymph nodes. Int Immunol 18: 1541-1548 [Abstract] [Full Text]  
• Lizee, G., Radvanyi, L. G., Overwijk, W. W., Hwu, P. (2006). Improving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms.. Clin. Cancer Res. 12: 4794-4803 [Abstract] [Full Text]  
• Bechetoille, N., Andre, V., Valladeau, J., Perrier, E., Dezutter-Dambuyant, C. (2006). Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli. J. Leukoc. Biol. 80: 45-58 [Abstract] [Full Text]  
• Tazi, A. (2006). Adult pulmonary Langerhans' cell histiocytosis.. Eur Respir J 27: 1272-1285 [Abstract] [Full Text]  
• Li, R., Rosendahl, A., Brodin, G., Cheng, A. M., Ahgren, A., Sundquist, C., Kulkarni, S., Pawson, T., Heldin, C.-H., Heuchel, R. L. (2006). Deletion of Exon I of SMAD7 in Mice Results in Altered B Cell Responses.. J. Immunol. 176: 6777-6784 [Abstract] [Full Text]  
• Ito, M., Minamiya, Y., Kawai, H., Saito, S., Saito, H., Nakagawa, T., Imai, K., Hirokawa, M., Ogawa, J.-i. (2006). Tumor-Derived TGFbeta-1 Induces Dendritic Cell Apoptosis in the Sentinel Lymph Node. J. Immunol. 176: 5637-5643 [Abstract] [Full Text]  
• Heinz, L. X., Platzer, B., Reisner, P. M., Jorgl, A., Taschner, S., Gobel, F., Strobl, H. (2006). Differential involvement of PU.1 and Id2 downstream of TGF-beta1 during Langerhans-cell commitment. Blood 107: 1445-1453 [Abstract] [Full Text]  
• Mende, I., Karsunky, H., Weissman, I. L., Engleman, E. G., Merad, M. (2006). Flk2+ myeloid progenitors are the main source of Langerhans cells. Blood 107: 1383-1390 [Abstract] [Full Text]  
• Gautier, G., de Saint-Vis, B., Senechal, B., Pin, J.-J., Bates, E. E.M., Caux, C., Geissmann, F., Garrone, P. (2006). The Class 6 Semaphorin SEMA6A Is Induced by Interferon-{gamma} and Defines an Activation Status of Langerhans Cells Observed in Pathological Situations. Am. J. Pathol. 168: 453-465 [Abstract] [Full Text]  
• Guess, J. C., McCance, D. J. (2005). Decreased Migration of Langerhans Precursor-Like Cells in Response to Human Keratinocytes Expressing Human Papillomavirus Type 16 E6/E7 Is Related to Reduced Macrophage Inflammatory Protein-3{alpha} Production. J. Virol. 79: 14852-14862 [Abstract] [Full Text]  
• Mao, A., Paharkova-Vatchkova, V., Hardy, J., Miller, M. M., Kovats, S. (2005). Estrogen Selectively Promotes the Differentiation of Dendritic Cells with Characteristics of Langerhans Cells. J. Immunol. 175: 5146-5151 [Abstract] [Full Text]  
• Rossi, M., Young, J. W. (2005). Human Dendritic Cells: Potent Antigen-Presenting Cells at the Crossroads of Innate and Adaptive Immunity. J. Immunol. 175: 1373-1381 [Abstract] [Full Text]  
• Menges, M., Baumeister, T., Rossner, S., Stoitzner, P., Romani, N., Gessner, A., Lutz, M. B. (2005). IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity. J. Leukoc. Biol. 77: 535-543 [Abstract] [Full Text]  
• Radeke, H. H., von Wenckstern, H., Stoidtner, K., Sauer, B., Hammer, S., Kleuser, B. (2005). Overlapping Signaling Pathways of Sphingosine 1-Phosphate and TGF-{beta} in the Murine Langerhans Cell Line XS52. J. Immunol. 174: 2778-2786 [Abstract] [Full Text]  
• Lyakh, L. A., Sanford, M., Chekol, S., Young, H. A., Roberts, A. B. (2005). TGF-{beta} and Vitamin D3 Utilize Distinct Pathways to Suppress IL-12 Production and Modulate Rapid Differentiation of Human Monocytes into CD83+ Dendritic Cells. J. Immunol. 174: 2061-2070 [Abstract] [Full Text]  
• Kissenpfennig, A., Ait-Yahia, S., Clair-Moninot, V., Stossel, H., Badell, E., Bordat, Y., Pooley, J. L., Lang, T., Prina, E., Coste, I., Gresser, O., Renno, T., Winter, N., Milon, G., Shortman, K., Romani, N., Lebecque, S., Malissen, B., Saeland, S., Douillard, P. (2005). Disruption of the langerin/CD207 Gene Abolishes Birbeck Granules without a Marked Loss of Langerhans Cell Function. Mol. Cell. Biol. 25: 88-99 [Abstract] [Full Text]  
• Ratzinger, G., Baggers, J., de Cos, M. A., Yuan, J., Dao, T., Reagan, J. L., Munz, C., Heller, G., Young, J. W. (2004). Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or Monocyte-Derived Dendritic Cells. J. Immunol. 173: 2780-2791 [Abstract] [Full Text]  
• Wang, Z., Castellaneta, A., De Creus, A., Shufesky, W. J., Morelli, A. E., Thomson, A. W. (2004). Heart, but Not Skin, Allografts from Donors Lacking Flt3 Ligand Exhibit Markedly Prolonged Survival Time. J. Immunol. 172: 5924-5930 [Abstract] [Full Text]  
• O'Neill, H. C., Wilson, H. L. (2004). Limitations with in vitro production of dendritic cells using cytokines. J. Leukoc. Biol. 75: 600-603 [Abstract] [Full Text]  
• Geissmann, F., Revy, P., Brousse, N., Lepelletier, Y., Folli, C., Durandy, A., Chambon, P., Dy, M. (2003). Retinoids Regulate Survival and Antigen Presentation by Immature Dendritic Cells. JEM 198: 623-634 [Abstract] [Full Text]  
• Ritter, U., Meissner, A., Ott, J., Korner, H. (2003). Analysis of the maturation process of dendritic cells deficient for TNF and lymphotoxin-{alpha} reveals an essential role for TNF. J. Leukoc. Biol. 74: 216-222 [Abstract] [Full Text]  
• Yoshino, M., Yamazaki, H., Nakano, H., Kakiuchi, T., Ryoke, K., Kunisada, T., Hayashi, S.-I. (2003). Distinct antigen trafficking from skin in the steady and active states. Int Immunol 15: 773-779 [Abstract] [Full Text]  
• Zhao, X., Deak, E., Soderberg, K., Linehan, M., Spezzano, D., Zhu, J., Knipe, D. M., Iwasaki, A. (2003). Vaginal Submucosal Dendritic Cells, but Not Langerhans Cells, Induce Protective Th1 Responses to Herpes Simplex Virus-2. JEM 197: 153-162 [Abstract] [Full Text]  
• Beaulieu, S., Robbiani, D. F., Du, X., Rodrigues, E., Ignatius, R., Wei, Y., Ponath, P., Young, J. W., Pope, M., Steinman, R. M., Mojsov, S. (2002). Expression of a Functional Eotaxin (CC Chemokine Ligand 11) Receptor CCR3 by Human Dendritic Cells. J. Immunol. 169: 2925-2936 [Abstract] [Full Text]  
• Randolph, G. J. (2002). Is Maturation Required for Langerhans Cell Migration?. JEM 196: 413-416 [Full Text]  
• Randolph, G. J., Sanchez-Schmitz, G., Liebman, R. M., Schakel, K. (2002). The CD16+ (Fc{gamma}RIII+) Subset of Human Monocytes Preferentially Becomes Migratory Dendritic Cells in a Model Tissue Setting. JEM 196: 517-527 [Abstract] [Full Text]  
• Woltman, A. M., Massacrier, C., de Fijter, J. W., Caux, C., van Kooten, C. (2002). Corticosteroids Prevent Generation of CD34+-Derived Dermal Dendritic Cells But Do Not Inhibit Langerhans Cell Development. J. Immunol. 168: 6181-6188 [Abstract] [Full Text]  
• Guironnet, G., Dezutter-Dambuyant, C., Bechetoille, C. V. N., Schmitt, D., Peguet-Navarro, J. (2002). Antagonistic effects of IL-4 and TGF-{beta}1 on Langerhans cell-related antigen expression by human monocytes. J. Leukoc. Biol. 71: 845-853 [Abstract] [Full Text]  
• Takahara, K., Omatsu, Y., Yashima, Y., Maeda, Y., Tanaka, S., Iyoda, T., Clusen, B., Matsubara, K., Letterio, J., Steinman, R. M., Matsuda, Y., Inaba, K. (2002). Identification and expression of mouse Langerin (CD207) in dendritic cells. Int Immunol 14: 433-444 [Abstract] [Full Text]  
• Relloso, M., Puig-Kroger, A., Pello, O. M., Rodriguez-Fernandez, J. L., de la Rosa, G., Longo, N., Navarro, J., Munoz-Fernandez, M. A., Sanchez-Mateos, P., Corbi, A. L. (2002). DC-SIGN (CD209) Expression Is IL-4 Dependent and Is Negatively Regulated by IFN, TGF-{beta}, and Anti-Inflammatory Agents. J. Immunol. 168: 2634-2643 [Abstract] [Full Text]  
• Iwama, A., Osawa, M., Hirasawa, R., Uchiyama, N., Kaneko, S., Onodera, M., Shibuya, K., Shibuya, A., Vinson, C., Tenen, D. G., Nakauchi, H. (2002). Reciprocal Roles for CCAAT/Enhancer Binding Protein (C/EBP) and PU.1 Transcription Factors in Langerhans Cell Commitment. JEM 195: 547-558 [Abstract] [Full Text]  
• Valladeau, J., Clair-Moninot, V., Dezutter-Dambuyant, C., Pin, J.-J., Kissenpfennig, A., Mattei, M.-G., Ait-Yahia, S., Bates, E. E. M., Malissen, B., Koch, F., Fossiez, F., Romani, N., Lebecque, S., Saeland, S. (2002). Identification of Mouse Langerin/CD207 in Langerhans Cells and Some Dendritic Cells of Lymphoid Tissues. J. Immunol. 168: 782-792 [Abstract] [Full Text]  
• Lipscomb, M. F., Masten, B. J. (2002). Dendritic Cells: Immune Regulators in Health and Disease. Physiol. Rev. 82: 97-130 [Abstract] [Full Text]  
• Dieu-Nosjean, M.-C., Massacrier, C., Vanbervliet, B., Fridman, W.-H., Caux, C. (2001). IL-10 Induces CCR6 Expression During Langerhans Cell Development While IL-4 and IFN-{gamma} Suppress It. J. Immunol. 167: 5594-5602 [Abstract] [Full Text]  
• Mohamadzadeh, M., Berard, F., Essert, G., Chalouni, C., Pulendran, B., Davoust, J., Bridges, G., Palucka, A. K., Banchereau, J. (2001). Interleukin 15 Skews Monocyte Differentiation into Dendritic Cells with Features of Langerhans Cells. JEM 194: 1013-1020 [Abstract] [Full Text]  
• Halliday, G. M., Le, S. (2001). Transforming growth factor-{beta} produced by progressor tumors inhibits, while IL-10 produced by regressor tumors enhances, Langerhans cell migration from skin. Int Immunol 13: 1147-1154 [Abstract] [Full Text]  
• Tindle, R. W., Herd, K., Doan, T., Bryson, G., Leggatt, G. R., Lambert, P., Frazer, I. H., Street, M. (2001). Nonspecific Down-Regulation of CD8+ T-Cell Responses in Mice Expressing Human Papillomavirus Type 16 E7 Oncoprotein from the Keratin-14 Promoter. J. Virol. 75: 5985-5997 [Abstract] [Full Text]  
• Hemmi, H., Yoshino, M., Yamazaki, H., Naito, M., Iyoda, T., Omatsu, Y., Shimoyama, S., Letterio, J. J., Nakabayashi, T., Tagaya, H., Yamane, T., Ogawa, M., Nishikawa, S.-I., Ryoke, K., Inaba, K., Hayashi, S.-I., Kunisada, T. (2001). Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-{beta}1-dependent cells. Int Immunol 13: 695-704 [Abstract] [Full Text]  
• THURNHER, M., ZELLE-RIESER, C., RAMONER, R., BARTSCH, G., HOLTL, L. (2001). The disabled dendritic cell. FASEB J. 15: 1054-1061 [Abstract] [Full Text]  
• Riedl, E., Stockl, J., Majdic, O., Scheinecker, C., Knapp, W., Strobl, H. (2000). Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood 96: 4276-4284 [Abstract] [Full Text]  
• Spanbroek, R., Hildner, M., Steinhilber, D., Fusenig, N., Yoneda, K., Samuelsson, O. R. B., Habenicht, A. J.R. (2000). 5-lipoxygenase expression in dendritic cells generated from CD34+ hematopoietic progenitors and in lymphoid organs. Blood 96: 3857-3865 [Abstract] [Full Text]  
• Dieu-Nosjean, M.-C., Massacrier, C., Homey, B., Vanbervliet, B., Pin, J.-J., Vicari, A., Lebecque, S., Dezutter-Dambuyant, C., Schmitt, D., Zlotnik, A., Caux, C. (2000). Macrophage Inflammatory Protein 3{alpha} Is Expressed at Inflamed Epithelial Surfaces and Is the Most Potent Chemokine Known in Attracting Langerhans Cell Precursors. JEM 192: 705-718 [Abstract] [Full Text]  
• Anjuere, F., del Hoyo, G. M., Martin, P., Ardavin, C. (2000). Langerhans cells develop from a lymphoid-committed precursor. Blood 96: 1633-1637 [Abstract] [Full Text]  
• Riedl, E., Stockl, J., Majdic, O., Scheinecker, C., Rappersberger, K., Knapp, W., Strobl, H. (2000). Functional Involvement of E-Cadherin in TGF-{beta}1-Induced Cell Cluster Formation of In Vitro Developing Human Langerhans-Type Dendritic Cells. J. Immunol. 165: 1381-1386 [Abstract] [Full Text]  
• De Creus, A., Van Beneden, K., Taghon, T., Stolz, F., Debacker, V., Plum, J., Leclercq, G. (2000). Langerhans Cells That Have Matured In Vivo in the Absence of T Cells Are Fully Capable of Inducing a Helper CD4 as Well as a Cytotoxic CD8 Response. J. Immunol. 165: 645-653 [Abstract] [Full Text]  
• Emile, J.-F., Geissmann, F., Martin, O. d. l. C., Radford-Weiss, I., Lepelletier, Y., Heymer, B., Espanol, T., de Santes, K. B., Bertrand, Y., Brousse, N., Casanova, J.-L., Fischer, A. (2000). Langerhans cell deficiency in reticular dysgenesis. Blood 96: 58-62 [Abstract] [Full Text]  
• McKenna, H. J., Stocking, K. L., Miller, R. E., Brasel, K., De Smedt, T., Maraskovsky, E., Maliszewski, C. R., Lynch, D. H., Smith, J., Pulendran, B., Roux, E. R., Teepe, M., Lyman, S. D., Peschon, J. J. (2000). Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95: 3489-3497 [Abstract] [Full Text]  
• Tazi, A., Soler, P., Hance, A. J (2000). Rare diseases bullet 9: Adult pulmonary Langerhans' cell histiocytosis. Thorax 55: 405-416 [Full Text]  
• Lauzurica, P., Sancho, D., Torres, M., Albella, B., Marazuela, M., Merino, T., Bueren, J. A., Martinez-A, C., Sanchez-Madrid, F. (2000). Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice. Blood 95: 2312-2320 [Abstract] [Full Text]  
• Brenner, M., Rossig, C., Sili, U., Young, J. W., Goulmy, E. (2000). Transfusion Medicine: New Clinical Applications of Cellular Immunotherapy. ASH Education Book 2000: 356-375 [Abstract] [Full Text]  
• Zhang, Y., Zhang, Y., Wang, Y., Ogata, M., Hashimoto, S.-i., Onai, N., Matsushima, K. (2000). Development of dendritic cells in vitro from murine fetal liver-derived lineage phenotype-negative c-kit+ hematopoietic progenitor cells. Blood 95: 138-146 [Abstract] [Full Text]  
• MacDonald, K. P. A., Pettit, A. R., Quinn, C., Thomas, G. J., Thomas, R. (1999). Resistance of Rheumatoid Synovial Dendritic Cells to the Immunosuppressive Effects of IL-10. J. Immunol. 163: 5599-5607 [Abstract] [Full Text]  
• Jaksits, S., Kriehuber, E., Charbonnier, A. S., Rappersberger, K., Stingl, G., Maurer, D. (1999). CD34+ Cell-Derived CD14+ Precursor Cells Develop into Langerhans Cells in a TGF-{beta}1-Dependent Manner. J. Immunol. 163: 4869-4877 [Abstract] [Full Text]  
• Ito, T., Inaba, M., Inaba, K., Toki, J., Sogo, S., Iguchi, T., Adachi, Y., Yamaguchi, K., Amakawa, R., Valladeau, J., Saeland, S., Fukuhara, S., Ikehara, S. (1999). A CD1a+/CD11c+ Subset of Human Blood Dendritic Cells Is a Direct Precursor of Langerhans Cells. J. Immunol. 163: 1409-1419 [Abstract] [Full Text]  
• Arnold, R., Seifert, M., Asadullah, K., Volk, H. D. (1999). Crosstalk Between Keratinocytes and T Lymphocytes via Fas/Fas Ligand Interaction: Modulation by Cytokines. J. Immunol. 162: 7140-7147 [Abstract] [Full Text]  
• Geissmann, F., Revy, P., Regnault, A., Lepelletier, Y., Dy, M., Brousse, N., Amigorena, S., Hermine, O., Durandy, A. (1999). TGF-{beta}1 Prevents the Noncognate Maturation of Human Dendritic Langerhans Cells. J. Immunol. 162: 4567-4575 [Abstract] [Full Text]  
• Zhang, Y., Zhang, Y.-y., Ogata, M., Chen, P., Harada, A., Hashimoto, S.-i., Matsushima, K. (1999). Transforming Growth Factor-beta 1 Polarizes Murine Hematopoietic Progenitor Cells to Generate Langerhans Cell-Like Dendritic Cells Through a Monocyte/Macrophage Differentiation Pathway. Blood 93: 1208-1220 [Abstract] [Full Text]  
• Kocikova, A., Kolesaric, A., Koszik, F., Stingl, G., Elbe-Burger, A. (1998). Murine Langerhans Cells Cultured Under Serum-Free Conditions Mature into Potent Stimulators of Primary Immune Responses In Vitro and In Vivo. J. Immunol. 161: 4033-4041 [Abstract] [Full Text]  
• Varas, A., Vicente, A., Sacedon, R., Zapata, A. G. (1998). Interleukin-7 Influences the Development of Thymic Dendritic Cells. Blood 92: 93-100 [Abstract] [Full Text]  
• Zhang, Y., Harada, A., Wang, J.-b., Zhang, Y.-y., Hashimoto, S.-i., Naito, M., Matsushima, K. (1998). Bifurcated Dendritic Cell Differentiation In Vitro From Murine Lineage Phenotype-Negative c-kit+ Bone Marrow Hematopoietic Progenitor Cells. Blood 92: 118-128 [Abstract] [Full Text]  
• Shores, E. W., Ono, M., Kawabe, T., Sommers, C. L., Tran, T., Lui, K., Udey, M. C., Ravetch, J., Love, P. E. (1998). T Cell Development in Mice Lacking All T Cell Receptor {zeta} Family Members ({zeta}, {eta}, and Fc{varepsilon}RI{gamma}). JEM 187: 1093-1101 [Abstract] [Full Text]  
• Geissmann, F., Prost, C., Monnet, J.-P., Dy, M., Brousse, N., Hermine, O. (1998). Transforming Growth Factor {beta}1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans Cells. JEM 187: 961-966 [Abstract] [Full Text]  
• Salomon, B., Cohen, J. L., Masurier, C., Klatzmann, D. (1998). Three Populations of Mouse Lymph Node Dendritic Cells with Different Origins and Dynamics. J. Immunol. 160: 708-717 [Abstract] [Full Text]  
• Zhang, Y., Mukaida, N., Wang, J.-b., Harada, A., Akiyama, M., Matsushima, K. (1997). Induction of Dendritic Cell Differentiation by Granulocyte-Macrophage Colony-Stimulating Factor, Stem Cell Factor, and Tumor Necrosis Factor alpha  In Vitro From Lineage Phenotypes-Negative c-kit+ Murine Hematopoietic Progenitor Cells. Blood 90: 4842-4853 [Abstract] [Full Text]  
• Reddy, A., Sapp, M., Feldman, M., Subklewe, M., Bhardwaj, N. (1997). A Monocyte Conditioned Medium Is More Effective Than Defined Cytokines in Mediating the Terminal Maturation of Human Dendritic Cells. Blood 90: 3640-3646 [Abstract] [Full Text]  
• Strobl, H., Bello-Fernandez, C., Riedl, E., Pickl, W. F., Majdic, O., Lyman, S. D., Knapp, W. (1997). flt3 Ligand in Cooperation With Transforming Growth Factor-beta 1 Potentiates In Vitro Development of Langerhans-Type Dendritic Cells and Allows Single-Cell Dendritic Cell Cluster Formation Under Serum-Free Conditions. Blood 90: 1425-1434 [Abstract] [Full Text]  
• Strunk, D., Egger, C., Leitner, G., Hanau, D., Stingl, G. (1997). A Skin Homing Molecule Defines the Langerhans Cell Progenitor in Human Peripheral Blood. JEM 185: 1131-1136 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF, 346K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Borkowski, T. A. Articles by Udey, M. C. Search for Related Content PubMed PubMed Citation Articles by Borkowski, T. A. Articles by Udey, M. C. Social Bookmarking                            What's this?